AmbioPharm Appoints Industry Veteran Brian Gregg as CEO

NORTH AUGUSTA, S.C., October 02, 2023--AmbioPharm, a worldwide leader in peptide active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO) services, announced the appointment of industry veteran Brian Gregg as Chief Executive Officer, today. Mr. Gregg, who has more than 30 years of experience in the peptide CDMO industry, succeeds Tim Nieters, who will be stepping down after 7 years with the company.

Related Keywords

South Carolina ,United States ,China ,San Diego State University ,California ,Ling Yang ,Hunan ,Shanghai ,North Augusta ,America ,Tim Nieters ,Juncai Chris Bai ,University Of California At San Diego ,Brian Gregg ,Chief Executive Officer ,Bachem Americas ,Chief Operating Officer ,Managing Director ,Active Pharmaceutical Ingredients ,New Chemical Entities ,North America ,Manufacturing Organization ,Dmo ,Global Customer Base ,